The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030,

BRIGHTON, Colo. - June 22, 2020 - PRLog -- The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

§  A  detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing

§  Elaborate profiles of some of the key contract manufacturers active in the pharmaceutical and biopharmaceutical continuous manufacturing market

§  An analysis of the various partnerships related to continuous manufacturing, which have been established since 2013

§  An analysis of the expansions related to continuous manufacturing, which have been established since 2013

§  An estimate of the global, continuous manufacturing capacity, based on the capacities of various industry stakeholders (as available on their respective company websites).

§  A study of the various grants that have been awarded to research institutes engaged in projects related to continuous manufacturing, between 2014 and 2019

§  An in-depth analysis of the various patents that have been filed / granted related to continuous manufacturing till 2019

§  Initiatives taken by the leading pharmaceutical companies (in terms of revenues), covering both partnered as well as in-house projects.

§  A review of the companies offering modular facilities / modular cleanrooms

§  A case study of the companies offering technologies / equipment

§  A case study on the roadmap for the adoption of continuous manufacturing technique

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Purpose of Manufacturing

§  In-House

§  Contract service

§  Scale of Operation

§  Commercial

§  Preclinical / Clinical

§  Type of Continuous Manufacturing related Service

§  API Manufacturing

§  End Product manufacturing

§  Type of Drug Molecule

§  Biologic

§  Small Molecule

§  Type of dosage form

§  Solid

§  Liquid

§  Key Geographical Regions

§  North America

§  Europe

§  Asia Pacifi

Key companies covered in the report (https://www.rootsanalysis.com/reports/view_document/conti...)

§  AbbVie Contract Manufacturing

§  Ajinomoto Bio-Pharma Services

§  Almac

§  Boehringer Ingelheim BioXcellence

§  Cambrex

§  CordonPharma

§  Hovione

§  Kaneka

§  Lonza

§  Patheon

§  SK biotek

§  WuXi AppTec

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com